Cargando…

PPI Long Term Use: Risk of Neurological Adverse Events?

The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the...

Descripción completa

Detalles Bibliográficos
Autores principales: Novotny, Michal, Klimova, Blanka, Valis, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331532/
https://www.ncbi.nlm.nih.gov/pubmed/30671013
http://dx.doi.org/10.3389/fneur.2018.01142
_version_ 1783387152733700096
author Novotny, Michal
Klimova, Blanka
Valis, Martin
author_facet Novotny, Michal
Klimova, Blanka
Valis, Martin
author_sort Novotny, Michal
collection PubMed
description The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the research topic describing the adverse effect of proton pum inhibitors (PPIs) (omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, dexrabeprazole, ilaprazole). For a long time, PPIs were considered to be completely safe drug substances for both short and long-term use. In recent years, there have been a few contradictory studis of absolute safety, especially in patients, who have long been using PPIs. At this time when depression and dementia are rising in the population, this is a very worrying fact that needs to be highlighted, and which needs to be carefully studied and evaluated, ideally trying to prevent it. The findings of most research studies described in this review indicate that there is a direct association between the onset of dementia and depression on one side and the long-term use of PPIs on the other.
format Online
Article
Text
id pubmed-6331532
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63315322019-01-22 PPI Long Term Use: Risk of Neurological Adverse Events? Novotny, Michal Klimova, Blanka Valis, Martin Front Neurol Neurology The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the research topic describing the adverse effect of proton pum inhibitors (PPIs) (omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, dexrabeprazole, ilaprazole). For a long time, PPIs were considered to be completely safe drug substances for both short and long-term use. In recent years, there have been a few contradictory studis of absolute safety, especially in patients, who have long been using PPIs. At this time when depression and dementia are rising in the population, this is a very worrying fact that needs to be highlighted, and which needs to be carefully studied and evaluated, ideally trying to prevent it. The findings of most research studies described in this review indicate that there is a direct association between the onset of dementia and depression on one side and the long-term use of PPIs on the other. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331532/ /pubmed/30671013 http://dx.doi.org/10.3389/fneur.2018.01142 Text en Copyright © 2019 Novotny, Klimova and Valis. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Novotny, Michal
Klimova, Blanka
Valis, Martin
PPI Long Term Use: Risk of Neurological Adverse Events?
title PPI Long Term Use: Risk of Neurological Adverse Events?
title_full PPI Long Term Use: Risk of Neurological Adverse Events?
title_fullStr PPI Long Term Use: Risk of Neurological Adverse Events?
title_full_unstemmed PPI Long Term Use: Risk of Neurological Adverse Events?
title_short PPI Long Term Use: Risk of Neurological Adverse Events?
title_sort ppi long term use: risk of neurological adverse events?
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331532/
https://www.ncbi.nlm.nih.gov/pubmed/30671013
http://dx.doi.org/10.3389/fneur.2018.01142
work_keys_str_mv AT novotnymichal ppilongtermuseriskofneurologicaladverseevents
AT klimovablanka ppilongtermuseriskofneurologicaladverseevents
AT valismartin ppilongtermuseriskofneurologicaladverseevents